Kinesiotherapy to improve the quality of life of women with Breast Cancer undergoing chemotherapy

Efficacy of Kinesiotherapy on fatigue, quality of life, and functional capacity in women with Breast Cancer undergoing chemotherapy: a randomized clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-3ryxgfr

Enrollment

Registered

2026-06-26

Start date

2026-04-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms Malignant Breast Neoplasm

Interventions

This is a single-blind, two-arm, randomized controlled clinical trial. Participants in the study will be women diagnosed with breast cancer, aged 18 years or older, and undergoing outpatient chemother

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women aged 18 or older; diagnosed with breast cancer; undergoing outpatient chemotherapy

Exclusion criteria

Exclusion criteria: Women with some cognitive impairment; with contraindications to kinesiotherapy

Design outcomes

Primary

Measure	Time frame
It is expected that kinesiotherapy can improve the health-related quality of life of women with breast cancer during chemotherapy when compared to the control group	—

Secondary

Measure	Time frame
It is expected that kinesiotherapy can reduce fatigue levels and improve functional capacity in women with breast cancer during chemotherapy when compared to the control group	—

Countries

Contacts

Public ContactAdriana Nicolussi

Universidade Federal do Triângulo Mineiro

adriana.nicolussi@uftm.edu.br+55-34-37006706

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026